{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:37:47Z","timestamp":1761197867808,"version":"3.37.3"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus L\u00fcbeck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Complex dystonias are defined as dystonias that are accompanied by neurologic or systemic manifestations beyond movement disorders. Many syndromes or diseases can present with complex dystonia, either as the cardinal sign or as part of a multi-systemic manifestation. Complex dystonia often gradually develops in the disease course, but can also be present from the outset. If available, the diagnostic workup, disease-specific treatment, and management of patients with complex dystonias require a multi-disciplinary approach. This article summarizes current knowledge on complex dystonias with a particular view of recent developments with respect to advances in diagnosis and management, including causative treatments.<\/jats:p>","DOI":"10.1007\/s00702-020-02275-y","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T09:09:03Z","timestamp":1605258543000},"page":"431-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Complex dystonias: an update on diagnosis and care"],"prefix":"10.1007","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-5947","authenticated-orcid":false,"given":"Rebecca","family":"Herzog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Weissbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"B\u00e4umer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"M\u00fcnchau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"issue":"6","key":"2275_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.5603\/PJNNS.a2019.0062","volume":"53","author":"NH Akcakaya","year":"2019","unstructured":"Akcakaya NH, Haryanyan G, Mercan S, Sozer N, Ali A, Tombul T, Ozbek U, Ugur Iseri SA, Yapici Z (2019) Clinical and genetic spectrum of an orphan disease MPAN: a series with new variants and a novel phenotype. Neurol Neurochir Pol 53(6):476\u2013483. https:\/\/doi.org\/10.5603\/PJNNS.a2019.0062","journal-title":"Neurol Neurochir Pol"},{"issue":"3","key":"2275_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/hep.20601","volume":"41","author":"A Ala","year":"2005","unstructured":"Ala A, Borjigin J, Rochwarger A, Schilsky M (2005) Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 41(3):668\u2013670. https:\/\/doi.org\/10.1002\/hep.20601","journal-title":"Hepatology"},{"issue":"1","key":"2275_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","volume":"18","author":"A Albanese","year":"2011","unstructured":"Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, Gasser T, Krauss JK, Nardocci N, Newton A, Valls-Sole J (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18(1):5\u201318. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03042.x","journal-title":"Eur J Neurol"},{"key":"2275_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1750-1172-8-83","volume":"8","author":"M Alfadhel","year":"2013","unstructured":"Alfadhel M, Almuntashri M, Jadah RH, Bashiri FA, Al Rifai MT, Al Shalaan H, Al Balwi M, Al Rumayan A, Eyaid W, Al-Twaijri W (2013) Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis 8:83. https:\/\/doi.org\/10.1186\/1750-1172-8-83","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2275_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0883073814531822","volume":"30","author":"AS Alter","year":"2015","unstructured":"Alter AS, Engelstad K, Hinton VJ, Montes J, Pearson TS, Akman CI, De Vivo DC (2015) Long-term clinical course of Glut1 deficiency syndrome. J Child Neurol 30(2):160\u2013169. https:\/\/doi.org\/10.1177\/0883073814531822","journal-title":"J Child Neurol"},{"issue":"11","key":"2275_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/dmcn.13167","volume":"58","author":"S Amalou","year":"2016","unstructured":"Amalou S, Gras D, Ilea A, Greneche MO, Francois L, Bellavoine V, Delanoe C, Auvin S (2016) Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol 58(11):1193\u20131199. https:\/\/doi.org\/10.1111\/dmcn.13167","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"2275_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1444-0938.2010.00504.x","volume":"94","author":"RA Armstrong","year":"2011","unstructured":"Armstrong RA (2011) Visual signs and symptoms of progressive supranuclear palsy. Clin Exp Optom 94(2):150\u2013160. https:\/\/doi.org\/10.1111\/j.1444-0938.2010.00504.x","journal-title":"Clin Exp Optom"},{"issue":"5","key":"2275_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80(5):496\u2013503. https:\/\/doi.org\/10.1212\/WNL.0b013e31827f0fd1","journal-title":"Neurology"},{"issue":"4","key":"2275_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/jnnp-2019-322169","volume":"91","author":"CA Artusi","year":"2020","unstructured":"Artusi CA, Dwivedi A, Romagnolo A, Bortolani S, Marsili L, Imbalzano G, Sturchio A, Keeling EG, Zibetti M, Contarino MF, Fasano A, Tagliati M, Okun MS, Espay AJ, Lopiano L, Merola A (2020) Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 91(4):426\u2013433. https:\/\/doi.org\/10.1136\/jnnp-2019-322169","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2275_CR10","volume-title":"Niemann-pick disease","author":"H Bajwa","year":"2020","unstructured":"Bajwa H, Azhar W (2020) Niemann-pick disease. StatPearls, Treasure Island"},{"issue":"4","key":"2275_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/jnnp.62.4.352","volume":"62","author":"CL Barclay","year":"1997","unstructured":"Barclay CL, Lang AE (1997) Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 62(4):352\u2013356. https:\/\/doi.org\/10.1136\/jnnp.62.4.352","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2275_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-2005-865714","volume":"36","author":"FA Baumeister","year":"2005","unstructured":"Baumeister FA, Auer DP, Hortnagel K, Freisinger P, Meitinger T (2005) The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome. Neuropediatrics 36(3):221\u2013222. https:\/\/doi.org\/10.1055\/s-2005-865714","journal-title":"Neuropediatrics"},{"issue":"3","key":"2275_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/mdc3.12399","volume":"4","author":"T Baumer","year":"2017","unstructured":"Baumer T, Sajin V, Munchau A (2017) Childhood-onset movement disorders: a clinical series of 606 cases. Mov Disord Clin Pract 4(3):437\u2013440. https:\/\/doi.org\/10.1002\/mdc3.12399","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"2275_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jpeds.2012.07.044","volume":"162","author":"R Benini","year":"2013","unstructured":"Benini R, Dagenais L, Shevell MI, de la Paralysie R, Quebec CC (2013) Normal imaging in patients with cerebral palsy: what does it tell us? J Pediatr 162(2):369\u2013374. https:\/\/doi.org\/10.1016\/j.jpeds.2012.07.044","journal-title":"J Pediatr"},{"issue":"4","key":"2275_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/02688690802233364","volume":"22","author":"PM Brennan","year":"2008","unstructured":"Brennan PM, Whittle IR (2008) Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain. Br J Neurosurg 22(4):508\u2013519. https:\/\/doi.org\/10.1080\/02688690802233364","journal-title":"Br J Neurosurg"},{"key":"2275_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","volume":"3","author":"P Brissot","year":"2012","unstructured":"Brissot P, Ropert M, Le Lan C, Loreal O (2012) Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 3:403\u2013410. https:\/\/doi.org\/10.1016\/j.bbagen.2011.07.014","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2275_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/mds.870010302","volume":"1","author":"RE Burke","year":"1986","unstructured":"Burke RE, Brin MF, Fahn S, Bressman SB, Moskowitz C (1986a) Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystonia. Mov Disord 1(3):163\u2013178. https:\/\/doi.org\/10.1002\/mds.870010302","journal-title":"Mov Disord"},{"issue":"2","key":"2275_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1212\/wnl.36.2.160","volume":"36","author":"RE Burke","year":"1986","unstructured":"Burke RE, Fahn S, Marsden CD (1986b) Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 36(2):160\u2013164. https:\/\/doi.org\/10.1212\/wnl.36.2.160","journal-title":"Neurology"},{"issue":"7","key":"2275_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.parkreldis.2011.05.002","volume":"17","author":"JF Burke","year":"2011","unstructured":"Burke JF, Dayalu P, Nan B, Askari F, Brewer GJ, Lorincz MT (2011) Prognostic significance of neurologic examination findings in Wilson disease. Parkinsonism Relat Disord 17(7):551\u2013556. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.05.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"2275_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/mds.26598","volume":"31","author":"FC Chang","year":"2016","unstructured":"Chang FC, Westenberger A, Dale RC, Smith M, Pall HS, Perez-Duenas B, Grattan-Smith P, Ouvrier RA, Mahant N, Hanna BC, Hunter M, Lawson JA, Max C, Sachdev R, Meyer E, Crimmins D, Pryor D, Morris JG, Munchau A, Grozeva D, Carss KJ, Raymond L, Kurian MA, Klein C, Fung VS (2016) Phenotypic insights into ADCY5-associated disease. Mov Disord 31(7):1033\u20131040. https:\/\/doi.org\/10.1002\/mds.26598","journal-title":"Mov Disord"},{"issue":"5","key":"2275_CR21","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/archneurol.2012.54","volume":"69","author":"YZ Chen","year":"2012","unstructured":"Chen YZ, Matsushita MM, Robertson P, Rieder M, Girirajan S, Antonacci F, Lipe H, Eichler EE, Nickerson DA, Bird TD, Raskind WH (2012) Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. Arch Neurol 69(5):630\u2013635. https:\/\/doi.org\/10.1001\/archneurol.2012.54","journal-title":"Arch Neurol"},{"key":"2275_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1469-8749.2007.tb12626.x","volume":"109","author":"C Christine","year":"2007","unstructured":"Christine C, Dolk H, Platt MJ, Colver A, Prasauskiene A, Krageloh-Mann I, Group SC (2007) Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy. Dev Med Child Neurol Suppl 109:35\u201338. https:\/\/doi.org\/10.1111\/j.1469-8749.2007.tb12626.x","journal-title":"Dev Med Child Neurol Suppl"},{"issue":"8","key":"2275_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM200102223440807","volume":"344","author":"PA Dennery","year":"2001","unstructured":"Dennery PA, Seidman DS, Stevenson DK (2001) Neonatal hyperbilirubinemia. N Engl J Med 344(8):581\u2013590. https:\/\/doi.org\/10.1056\/NEJM200102223440807","journal-title":"N Engl J Med"},{"issue":"11","key":"2275_CR24","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10072-019-03998-x","volume":"40","author":"G Donzuso","year":"2019","unstructured":"Donzuso G, Mostile G, Nicoletti A, Zappia M (2019) Basal ganglia calcifications (Fahr\u2019s syndrome): related conditions and clinical features. Neurol Sci 40(11):2251\u20132263. https:\/\/doi.org\/10.1007\/s10072-019-03998-x","journal-title":"Neurol Sci"},{"issue":"5","key":"2275_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/mds.27568","volume":"34","author":"D Ebrahimi-Fakhari","year":"2019","unstructured":"Ebrahimi-Fakhari D, Van Karnebeek C, Munchau A (2019) Movement disorders in treatable inborn errors of metabolism. Mov Disord 34(5):598\u2013613. https:\/\/doi.org\/10.1002\/mds.27568","journal-title":"Mov Disord"},{"issue":"7","key":"2275_CR106","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/ajmg.a.38252","volume":"173","author":"C Evers","year":"2017","unstructured":"Evers C, Seitz A, Assmann B, Opladen T, Karch S, Hinderhofer K, Granzow M, Paramasivam N, Eils R, Diessl N, Bartram CR, Moog U (2017) Diagnosis of CoPAN by whole exome sequencing: Waking up a sleeping tiger's eye. Am J Med Genet A 173(7):1878\u20131886. https:\/\/doi.org\/10.1002\/ajmg.a.38252","journal-title":"Am J Med Genet A"},{"issue":"2","key":"2275_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12031-019-01301-3","volume":"68","author":"S Giri","year":"2019","unstructured":"Giri S, Naiya T, Roy S, Das G, Wali GM, Das SK, Ray K, Ray J (2019) A compound heterozygote for GCH1 mutation represents a case of atypical dopa-responsive dystonia. J Mol Neurosci 68(2):214\u2013220. https:\/\/doi.org\/10.1007\/s12031-019-01301-3","journal-title":"J Mol Neurosci"},{"issue":"12","key":"2275_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.earlhumdev.2008.09.008","volume":"84","author":"K Gkoltsiou","year":"2008","unstructured":"Gkoltsiou K, Tzoufi M, Counsell S, Rutherford M, Cowan F (2008) Serial brain MRI and ultrasound findings: relation to gestational age, bilirubin level, neonatal neurologic status and neurodevelopmental outcome in infants at risk of kernicterus. Early Hum Dev 84(12):829\u2013838. https:\/\/doi.org\/10.1016\/j.earlhumdev.2008.09.008","journal-title":"Early Hum Dev"},{"issue":"2","key":"2275_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/mds.870100204","volume":"10","author":"P Greene","year":"1995","unstructured":"Greene P, Kang UJ, Fahn S (1995) Spread of symptoms in idiopathic torsion dystonia. Mov Disord 10(2):143\u2013152. https:\/\/doi.org\/10.1002\/mds.870100204","journal-title":"Mov Disord"},{"key":"2275_CR29","volume-title":"GeneReviews((R))","author":"A Gregory","year":"1993","unstructured":"Gregory A, Hayflick S (1993) Neurodegeneration with brain iron accumulation disorders overview. In: Adam MP, Ardinger HH, Pagon RA (eds) GeneReviews((R)). Statpearls, Seattle"},{"key":"2275_CR107","volume-title":"PLA2G6-Associated Neurodegeneration","author":"A Gregory","year":"1993","unstructured":"Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ (1993) In: Adam MP, Ardinger HH, Pagon RA et al (eds) PLA2G6-Associated Neurodegeneration. GeneReviews((R)), Seattle (WA)"},{"issue":"6","key":"2275_CR30","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.ajhg.2012.10.019","volume":"91","author":"TB Haack","year":"2012","unstructured":"Haack TB, Hogarth P, Kruer MC, Gregory A, Wieland T, Schwarzmayr T, Graf E, Sanford L, Meyer E, Kara E, Cuno SM, Harik SI, Dandu VH, Nardocci N, Zorzi G, Dunaway T, Tarnopolsky M, Skinner S, Frucht S, Hanspal E, Schrander-Stumpel C, Heron D, Mignot C, Garavaglia B, Bhatia K, Hardy J, Strom TM, Boddaert N, Houlden HH, Kurian MA, Meitinger T, Prokisch H, Hayflick SJ (2012) Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet 91(6):1144\u20131149. https:\/\/doi.org\/10.1016\/j.ajhg.2012.10.019","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2275_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa020817","volume":"348","author":"SJ Hayflick","year":"2003","unstructured":"Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J (2003) Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 348(1):33\u201340. https:\/\/doi.org\/10.1056\/NEJMoa020817","journal-title":"N Engl J Med"},{"key":"2275_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nyas.12343","volume":"1315","author":"W Hermann","year":"2014","unstructured":"Hermann W (2014) Morphological and functional imaging in neurological and non-neurological Wilson\u2019s patients. Ann N Y Acad Sci 1315:24\u201329. https:\/\/doi.org\/10.1111\/nyas.12343","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2275_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jht.2008.11.002","volume":"22","author":"LB Hinkley","year":"2009","unstructured":"Hinkley LB, Webster RL, Byl NN, Nagarajan SS (2009) Neuroimaging characteristics of patients with focal hand dystonia. J Hand Ther 22(2):125\u2013134. https:\/\/doi.org\/10.1016\/j.jht.2008.11.002","journal-title":"J Hand Ther"},{"issue":"1","key":"2275_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/mds.27140","volume":"33","author":"HA Jinnah","year":"2018","unstructured":"Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodriguez-Violante M, Schols L, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM, International Parkinson\u2019s Disease Movement Disorders Society Task Force on Rare Movement D (2018) Treatable inherited rare movement disorders. Mov Disord 33(1):21\u201335. https:\/\/doi.org\/10.1002\/mds.27140","journal-title":"Mov Disord"},{"issue":"14","key":"2275_CR35","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/mds.22756","volume":"24","author":"M Kitahara","year":"2009","unstructured":"Kitahara M, Shimohata T, Tokunaga J, Nishizawa M (2009) Cervical dystonia associated with spinocerebellar ataxia type 2 successfully treated with levodopa: a case report. Mov Disord 24(14):2163\u20132164. https:\/\/doi.org\/10.1002\/mds.22756","journal-title":"Mov Disord"},{"key":"2275_CR36","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/B978-0-444-59565-2.00059-9","volume":"113","author":"C Klein","year":"2013","unstructured":"Klein C, Munchau A (2013) Progressive dystonia. Handb Clin Neurol 113:1889\u20131897. https:\/\/doi.org\/10.1016\/B978-0-444-59565-2.00059-9","journal-title":"Handb Clin Neurol"},{"key":"2275_CR37","volume-title":"GeneReviews((R))","author":"C Klein","year":"1993","unstructured":"Klein C, Lohmann K, Marras C, Munchau A (1993) Hereditary dystonia overview. In: Adam MP, Ardinger HH, Pagon RA (eds) GeneReviews((R)). Statpearls, Seattle"},{"issue":"7","key":"2275_CR38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S1474-4422(19)30142-5","volume":"18","author":"T Klopstock","year":"2019","unstructured":"Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmiec T, Buchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Kupper C, Neuhofer C, Kalman B, Dusek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E (2019) Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol 18(7):631\u2013642. https:\/\/doi.org\/10.1016\/S1474-4422(19)30142-5","journal-title":"Lancet Neurol"},{"issue":"6","key":"2275_CR39","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/mds.870090605","volume":"9","author":"P Krack","year":"1994","unstructured":"Krack P, Marion MH (1994) \u201cApraxia of lid opening,\u201d a focal eyelid dystonia: clinical study of 32 patients. Mov Disord 9(6):610\u2013615. https:\/\/doi.org\/10.1002\/mds.870090605","journal-title":"Mov Disord"},{"key":"2275_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/B978-0-12-410502-7.00003-X","volume":"110","author":"MA Kurian","year":"2013","unstructured":"Kurian MA, Hayflick SJ (2013) Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes. Int Rev Neurobiol 110:49\u201371. https:\/\/doi.org\/10.1016\/B978-0-12-410502-7.00003-X","journal-title":"Int Rev Neurobiol"},{"key":"2275_CR108","doi-asserted-by":"publisher","first-page":"(3):441\u2013445","DOI":"10.1002\/mds.22435","volume":"Disord24","author":"A Kubota","year":"2009","unstructured":"Kubota A, Hida A, Ichikawa Y, Momose Y, Goto J, Igeta Y, Hashida H, Yoshida K, Ikeda S, Kanazawa I, Tsuji S (2009) A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations. Mov Disord 24:(3):441\u2013445. https:\/\/doi.org\/10.1002\/mds.22435","journal-title":"Mov"},{"issue":"2","key":"2275_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000120365","volume":"14","author":"A Legido","year":"1988","unstructured":"Legido A, Zimmerman RA, Packer RJ, Bilaniuk LT, Siegel KR, D\u2019Angio G (1988) Significance of basal ganglia calcification on computed tomography in children. Pediatr Neurosci 14(2):64\u201370. https:\/\/doi.org\/10.1159\/000120365","journal-title":"Pediatr Neurosci"},{"issue":"4","key":"2275_CR42","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/WCO.0000000000000844","volume":"33","author":"S Lehericy","year":"2020","unstructured":"Lehericy S, Roze E, Goizet C, Mochel F (2020) MRI of neurodegeneration with brain iron accumulation. Curr Opin Neurol 33(4):462\u2013473. https:\/\/doi.org\/10.1097\/WCO.0000000000000844","journal-title":"Curr Opin Neurol"},{"key":"2275_CR43","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/B978-0-444-59565-2.00061-7","volume":"113","author":"D Letort","year":"2013","unstructured":"Letort D, Gonzalez-Alegre P (2013) Huntington\u2019s disease in children. Handb Clin Neurol 113:1913\u20131917. https:\/\/doi.org\/10.1016\/B978-0-444-59565-2.00061-7","journal-title":"Handb Clin Neurol"},{"key":"2275_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-981-13-9589-5_9","volume":"1173","author":"S Levi","year":"2019","unstructured":"Levi S, Cozzi A, Santambrogio P (2019) Iron pathophysiology in neurodegeneration with brain iron accumulation. Adv Exp Med Biol 1173:153\u2013177. https:\/\/doi.org\/10.1007\/978-981-13-9589-5_9","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"2275_CR45","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/jnnp-2013-307041","volume":"85","author":"JP Lin","year":"2014","unstructured":"Lin JP, Lumsden DE, Gimeno H, Kaminska M (2014) The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study. J Neurol Neurosurg Psychiatry 85(11):1239\u20131244. https:\/\/doi.org\/10.1136\/jnnp-2013-307041","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"2275_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cge.12629","volume":"89","author":"M Lingen","year":"2016","unstructured":"Lingen M, Albers L, Borchers M, Haass S, Gartner J, Schroder S, Goldbeck L, von Kries R, Brockmann K, Zirn B (2016) Obtaining a genetic diagnosis in a child with disability: impact on parental quality of life. Clin Genet 89(2):258\u2013266. https:\/\/doi.org\/10.1111\/cge.12629","journal-title":"Clin Genet"},{"key":"2275_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.nbd.2014.10.023","volume":"81","author":"F Maccarinelli","year":"2015","unstructured":"Maccarinelli F, Pagani A, Cozzi A, Codazzi F, Di Giacomo G, Capoccia S, Rapino S, Finazzi D, Politi LS, Cirulli F, Giorgio M, Cremona O, Grohovaz F, Levi S (2015) A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits. Neurobiol Dis 81:119\u2013133. https:\/\/doi.org\/10.1016\/j.nbd.2014.10.023","journal-title":"Neurobiol Dis"},{"issue":"12","key":"2275_CR48","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/mds.21170","volume":"21","author":"A Machado","year":"2006","unstructured":"Machado A, Chien HF, Deguti MM, Cancado E, Azevedo RS, Scaff M, Barbosa ER (2006) Neurological manifestations in Wilson\u2019s disease: report of 119 cases. Mov Disord 21(12):2192\u20132196. https:\/\/doi.org\/10.1002\/mds.21170","journal-title":"Mov Disord"},{"issue":"6","key":"2275_CR49","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ajog.2015.05.034","volume":"213","author":"AH MacLennan","year":"2015","unstructured":"MacLennan AH, Thompson SC, Gecz J (2015) Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol 213(6):779\u2013788. https:\/\/doi.org\/10.1016\/j.ajog.2015.05.034","journal-title":"Am J Obstet Gynecol"},{"key":"2275_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnins.2019.00325","volume":"13","author":"G Marchi","year":"2019","unstructured":"Marchi G, Busti F, Lira Zidanes A, Castagna A, Girelli D (2019) Aceruloplasminemia: a severe neurodegenerative disorder deserving an early diagnosis. Front Neurosci 13:325. https:\/\/doi.org\/10.3389\/fnins.2019.00325","journal-title":"Front Neurosci"},{"issue":"2","key":"2275_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10048-018-0538-8","volume":"19","author":"F Mari","year":"2018","unstructured":"Mari F, Berti B, Romano A, Baldacci J, Rizzi R, Grazia Alessandri M, Tessa A, Procopio E, Rubegni A, Lourenco CM, Simonati A, Guerrini R, Santorelli FM (2018) Clinical and neuroimaging features of autosomal recessive spastic paraplegia 35 (SPG35): case reports, new mutations, and brief literature review. Neurogenetics 19(2):123\u2013130. https:\/\/doi.org\/10.1007\/s10048-018-0538-8","journal-title":"Neurogenetics"},{"issue":"4","key":"2275_CR52","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/brain\/97.1.793","volume":"97","author":"CD Marsden","year":"1974","unstructured":"Marsden CD, Harrison MJ (1974) Idiopathic torsion dystonia (dystonia musculorum deformans). A review of forty-two patients. Brain 97(4):793\u2013810. https:\/\/doi.org\/10.1093\/brain\/97.1.793","journal-title":"Brain"},{"issue":"1","key":"2275_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/gut.2005.087262","volume":"56","author":"U Merle","year":"2007","unstructured":"Merle U, Schaefer M, Ferenci P, Stremmel W (2007) Clinical presentation, diagnosis and long-term outcome of Wilson\u2019s disease: a cohort study. Gut 56(1):115\u2013120. https:\/\/doi.org\/10.1136\/gut.2005.087262","journal-title":"Gut"},{"issue":"2","key":"2275_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ncl.2020.01.005","volume":"38","author":"C Mulligan","year":"2020","unstructured":"Mulligan C, Bronstein JM (2020) Wilson disease: an overview and approach to management. Neurol Clin 38(2):417\u2013432. https:\/\/doi.org\/10.1016\/j.ncl.2020.01.005","journal-title":"Neurol Clin"},{"issue":"4","key":"2275_CR55","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/jnnp.69.4.494","volume":"69","author":"A Munchau","year":"2000","unstructured":"Munchau A, Mathen D, Cox T, Quinn NP, Marsden CD, Bhatia KP (2000) Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystonia. J Neurol Neurosurg Psychiatry 69(4):494\u2013498. https:\/\/doi.org\/10.1136\/jnnp.69.4.494","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"2275_CR56","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00115-019-0750-2","volume":"90","author":"A Munchau","year":"2019","unstructured":"Munchau A, Schols L, Klein C, Graessner H (2019) Model for personalized diagnostics and treatment in neurology-German Academy for Rare Neurological Diseases. Nervenarzt 90(8):796\u2013803. https:\/\/doi.org\/10.1007\/s00115-019-0750-2","journal-title":"Nervenarzt"},{"issue":"12","key":"2275_CR57","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/archdischild-2013-305506","volume":"99","author":"BO Olusanya","year":"2014","unstructured":"Olusanya BO, Ogunlesi TA, Slusher TM (2014) Why is kernicterus still a major cause of death and disability in low-income and middle-income countries? Arch Dis Child 99(12):1117\u20131121. https:\/\/doi.org\/10.1136\/archdischild-2013-305506","journal-title":"Arch Dis Child"},{"issue":"2","key":"2275_CR58","doi-asserted-by":"publisher","first-page":"e0117229","DOI":"10.1371\/journal.pone.0117229","volume":"10","author":"BO Olusanya","year":"2015","unstructured":"Olusanya BO, Osibanjo FB, Slusher TM (2015) Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS ONE 10(2):e0117229. https:\/\/doi.org\/10.1371\/journal.pone.0117229","journal-title":"PLoS ONE"},{"issue":"1","key":"2275_CR59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13023-020-01379-8","volume":"15","author":"T Opladen","year":"2020","unstructured":"Opladen T, Lopez-Laso E, Cortes-Saladelafont E, Pearson TS, Sivri HS, Yildiz Y, Assmann B, Kurian MA, Leuzzi V, Heales S, Pope S, Porta F, Garcia-Cazorla A, Honzik T, Pons R, Regal L, Goez H, Artuch R, Hoffmann GF, Horvath G, Thony B, Scholl-Burgi S, Burlina A, Verbeek MM, Mastrangelo M, Friedman J, Wassenberg T, Jeltsch K, Kulhanek J, Hubschmann OH, International Working Group on Neurotransmitter related D (2020) Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies. Orphanet J Rare Dis 15(1):126. https:\/\/doi.org\/10.1186\/s13023-020-01379-8","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2275_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.pmr.2009.06.001","volume":"20","author":"AT Pakula","year":"2009","unstructured":"Pakula AT, Van Naarden BK, Yeargin-Allsopp M (2009) Cerebral palsy: classification and epidemiology. Phys Med Rehabil Clin N Am 20(3):425\u2013452. https:\/\/doi.org\/10.1016\/j.pmr.2009.06.001","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"1","key":"2275_CR61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-020-01363-2","volume":"15","author":"MC Patterson","year":"2020","unstructured":"Patterson MC, Mengel E, Vanier MT, Moneuse P, Rosenberg D, Pineda M (2020) Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry. Orphanet J Rare Dis 15(1):104. https:\/\/doi.org\/10.1186\/s13023-020-01363-2","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2275_CR62","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/mds.27655","volume":"34","author":"TS Pearson","year":"2019","unstructured":"Pearson TS, Pons R, Ghaoui R, Sue CM (2019) Genetic mimics of cerebral palsy. Mov Disord 34(5):625\u2013636. https:\/\/doi.org\/10.1002\/mds.27655","journal-title":"Mov Disord"},{"issue":"3","key":"2275_CR63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/mds.22808","volume":"25","author":"R Pons","year":"2010","unstructured":"Pons R, Collins A, Rotstein M, Engelstad K, De Vivo DC (2010) The spectrum of movement disorders in Glut-1 deficiency. Mov Disord 25(3):275\u2013281. https:\/\/doi.org\/10.1002\/mds.22808","journal-title":"Mov Disord"},{"issue":"1","key":"2275_CR64","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1006\/brcg.1993.1046","volume":"23","author":"E Pourcher","year":"1993","unstructured":"Pourcher E, Cohen H, Cohen D, Baruch P, Bouchard RH (1993) Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia. Brain Cogn 23(1):81\u201387. https:\/\/doi.org\/10.1006\/brcg.1993.1046","journal-title":"Brain Cogn"},{"key":"2275_CR65","doi-asserted-by":"publisher","DOI":"10.2217\/nmt.13.18","author":"OW Quarrell","year":"2013","unstructured":"Quarrell OW, Nance MA, Nopoulos P, Paulsen JS, Smith JA, Squitieri F (2013) Managing juvenile Huntington\u2019s disease. Neurodegener Dis Manag. https:\/\/doi.org\/10.2217\/nmt.13.18","journal-title":"Neurodegener Dis Manag"},{"key":"2275_CR66","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.toxicon.2014.07.009","volume":"90","author":"J Ramirez-Castaneda","year":"2014","unstructured":"Ramirez-Castaneda J, Jankovic J (2014) Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon 90:344\u2013348. https:\/\/doi.org\/10.1016\/j.toxicon.2014.07.009","journal-title":"Toxicon"},{"issue":"6","key":"2275_CR67","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/brain\/awz102","volume":"142","author":"TW Rattay","year":"2019","unstructured":"Rattay TW, Lindig T, Baets J, Smets K, Deconinck T, Sohn AS, Hortnagel K, Eckstein KN, Wiethoff S, Reichbauer J, Dobler-Neumann M, Krageloh-Mann I, Auer-Grumbach M, Plecko B, Munchau A, Wilken B, Janauschek M, Giese AK, De Bleecker JL, Ortibus E, Debyser M, Lopez de Munain A, Pujol A, Bassi MT, D\u2019Angelo MG, De Jonghe P, Zuchner S, Bauer P, Schols L, Schule R (2019) FAHN\/SPG35: a narrow phenotypic spectrum across disease classifications. Brain 142(6):1561\u20131572. https:\/\/doi.org\/10.1093\/brain\/awz102","journal-title":"Brain"},{"issue":"4","key":"2275_CR68","doi-asserted-by":"publisher","first-page":"7279","DOI":"10.4081\/ni.2017.7279","volume":"9","author":"M Rohani","year":"2017","unstructured":"Rohani M, Razmeh S, Shahidi GA, Alizadeh E, Orooji M (2017) A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients. Neurol Int 9(4):7279. https:\/\/doi.org\/10.4081\/ni.2017.7279","journal-title":"Neurol Int"},{"issue":"1","key":"2275_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.siny.2014.11.002","volume":"20","author":"J Rose","year":"2015","unstructured":"Rose J, Vassar R (2015) Movement disorders due to bilirubin toxicity. Semin Fetal Neonatal Med 20(1):20\u201325. https:\/\/doi.org\/10.1016\/j.siny.2014.11.002","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"2275_CR70","doi-asserted-by":"publisher","first-page":"93","DOI":"10.26574\/maedica.2019.14.2.93","volume":"14","author":"C Sandu","year":"2019","unstructured":"Sandu C, Burloiu CM, Barca DG, Magureanu SA, Craiu DC (2019) Ketogenic diet in patients with GLUT1 deficiency syndrome. Maedica (Buchar) 14(2):93\u201397. https:\/\/doi.org\/10.26574\/maedica.2019.14.2.93","journal-title":"Maedica (Buchar)"},{"key":"2275_CR71","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.nbd.2015.02.030","volume":"81","author":"P Santambrogio","year":"2015","unstructured":"Santambrogio P, Dusi S, Guaraldo M, Rotundo LI, Broccoli V, Garavaglia B, Tiranti V, Levi S (2015) Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients. Neurobiol Dis 81:144\u2013153. https:\/\/doi.org\/10.1016\/j.nbd.2015.02.030","journal-title":"Neurobiol Dis"},{"key":"2275_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103664","author":"P Santambrogio","year":"2020","unstructured":"Santambrogio P, Ripamonti M, Paolizzi C, Panteghini C, Carecchio M, Chiapparini L, Raimondi M, Rubio A, Di Meo I, Cozzi A, Taverna S, De Palma G, Tiranti V, Levi S (2020) Harmful iron-calcium relationship in pantothenate kinase associated neurodegeneration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21103664","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"2275_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1468-1331.2010.03051.x","volume":"17","author":"SA Schneider","year":"2010","unstructured":"Schneider SA, Bhatia KP (2010) Secondary dystonia\u2013clinical clues and syndromic associations. Eur J Neurol 17(Suppl 1):52\u201357. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03051.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"2275_CR109","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13023-020-1351-7","volume":"15","author":"M Schubert Baldo","year":"2020","unstructured":"Schubert Baldo M, Vilarinho L (2020) Correction to: Molecular basis of Leigh syndrome: a current look. Orphanet J Rare Dis 15(1):77. https:\/\/doi.org\/10.1186\/s13023-020-1351-7","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 2","key":"2275_CR74","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/S0929-693X(10)70012-9","volume":"17","author":"F Sedel","year":"2010","unstructured":"Sedel F (2010) Clinical diagnosis of the adult form of Niemann-Pick type C disease. Arch Pediatr 17(Suppl 2):S50-53. https:\/\/doi.org\/10.1016\/S0929-693X(10)70012-9","journal-title":"Arch Pediatr"},{"issue":"10","key":"2275_CR75","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1093\/brain\/awy230","volume":"141","author":"P Seibler","year":"2018","unstructured":"Seibler P, Burbulla LF, Dulovic M, Zittel S, Heine J, Schmidt T, Rudolph F, Westenberger A, Rakovic A, Munchau A, Krainc D, Klein C (2018) Iron overload is accompanied by mitochondrial and lysosomal dysfunction in WDR45 mutant cells. Brain 141(10):3052\u20133064. https:\/\/doi.org\/10.1093\/brain\/awy230","journal-title":"Brain"},{"issue":"1","key":"2275_CR76","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/sj.jp.7211157","volume":"25","author":"SM Shapiro","year":"2005","unstructured":"Shapiro SM (2005) Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 25(1):54\u201359. https:\/\/doi.org\/10.1038\/sj.jp.7211157","journal-title":"J Perinatol"},{"issue":"3","key":"2275_CR77","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.siny.2009.12.004","volume":"15","author":"SM Shapiro","year":"2010","unstructured":"Shapiro SM (2010) Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med 15(3):157\u2013163. https:\/\/doi.org\/10.1016\/j.siny.2009.12.004","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"2275_CR78","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41390-019-0603-5","volume":"87","author":"SM Shapiro","year":"2020","unstructured":"Shapiro SM, Riordan SM (2020) Review of bilirubin neurotoxicity II: preventing and treating acute bilirubin encephalopathy and kernicterus spectrum disorders. Pediatr Res 87(2):332\u2013337. https:\/\/doi.org\/10.1038\/s41390-019-0603-5","journal-title":"Pediatr Res"},{"key":"2275_CR79","doi-asserted-by":"publisher","first-page":"104462","DOI":"10.1016\/j.nbd.2019.05.001","volume":"132","author":"AS Shetty","year":"2019","unstructured":"Shetty AS, Bhatia KP, Lang AE (2019) Dystonia and Parkinson\u2019s disease: what is the relationship? Neurobiol Dis 132:104462. https:\/\/doi.org\/10.1016\/j.nbd.2019.05.001","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2275_CR80","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13023-020-1349-1","volume":"15","author":"M Smith","year":"2020","unstructured":"Smith M, Alexander E, Marcinkute R, Dan D, Rawson M, Banka S, Gavin J, Mina H, Hennessy C, Riccardi F, Radio FC, Havlovicova M, Cassina M, Emandi AC, Fradin M, Gompertz L, Nordgren A, Traberg R, Rossi M, Trimouille A, Sowmyalakshmi R, Dallapiccola B, Renieri A, Faivre L, Kerr B, Verloes A, Clayton-Smith J, Douzgou S, Ern I (2020) Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders. Orphanet J Rare Dis 15(1):103. https:\/\/doi.org\/10.1186\/s13023-020-1349-1","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2275_CR81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaneurol.2018.3230","volume":"76","author":"BML Stelten","year":"2019","unstructured":"Stelten BML, van Ommen W, Keizer K (2019) Neurodegeneration with brain iron accumulation: a novel mutation in the ceruloplasmin gene. JAMA Neurol 76(2):229\u2013230. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3230","journal-title":"JAMA Neurol"},{"key":"2275_CR82","doi-asserted-by":"publisher","DOI":"10.1080\/17518423.2020.1753841","author":"K Stewart","year":"2020","unstructured":"Stewart K, Copeland L, Lewis J (2020) The impact of intrathecal baclofen therapy on health-related quality of life for children with marked hypertonia. Dev Neurorehabil. https:\/\/doi.org\/10.1080\/17518423.2020.1753841","journal-title":"Dev Neurorehabil"},{"issue":"12","key":"2275_CR83","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1007\/s00415-019-09499-3","volume":"266","author":"M Svetel","year":"2019","unstructured":"Svetel M, Tomic A, Dragasevic N, Petrovic I, Kresojevic N, Jech R, Urgosik D, Banjac I, Vitkovic J, Novakovic I, Kostic VS (2019) Clinical course of patients with pantothenate kinase-associated neurodegeneration (PKAN) before and after DBS surgery. J Neurol 266(12):2962\u20132969. https:\/\/doi.org\/10.1007\/s00415-019-09499-3","journal-title":"J Neurol"},{"issue":"3","key":"2275_CR84","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1212\/WNL.0b013e31827deb4c","volume":"80","author":"B Tabarki","year":"2013","unstructured":"Tabarki B, Al-Shafi S, Al-Shahwan S, Azmat Z, Al-Hashem A, Al-Adwani N, Biary N, Al-Zawahmah M, Khan S, Zuccoli G (2013) Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. Neurology 80(3):261\u2013267. https:\/\/doi.org\/10.1212\/WNL.0b013e31827deb4c","journal-title":"Neurology"},{"issue":"5","key":"2275_CR85","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ejpn.2015.05.008","volume":"19","author":"B Tabarki","year":"2015","unstructured":"Tabarki B, Alfadhel M, AlShahwan S, Hundallah K, AlShafi S, AlHashem A (2015) Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone. Eur J Paediatr Neurol 19(5):547\u2013552. https:\/\/doi.org\/10.1016\/j.ejpn.2015.05.008","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"2275_CR86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00002826-199102000-00005","volume":"14","author":"AE Taylor","year":"1991","unstructured":"Taylor AE, Lang AE, Saint-Cyr JA, Riley DE, Ranawaya R (1991) Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies. Clin Neuropharmacol 14(1):62\u201377. https:\/\/doi.org\/10.1097\/00002826-199102000-00005","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"2275_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13311-013-0231-4","volume":"11","author":"MA Thenganatt","year":"2014","unstructured":"Thenganatt MA, Jankovic J (2014) Treatment of dystonia. Neurotherapeutics 11(1):139\u2013152. https:\/\/doi.org\/10.1007\/s13311-013-0231-4","journal-title":"Neurotherapeutics"},{"issue":"1","key":"2275_CR88","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ncl.2014.09.013","volume":"33","author":"MA Thenganatt","year":"2015","unstructured":"Thenganatt MA, Jankovic J (2015) Psychogenic movement disorders. Neurol Clin 33(1):205\u2013224. https:\/\/doi.org\/10.1016\/j.ncl.2014.09.013","journal-title":"Neurol Clin"},{"key":"2275_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116992","author":"Y Thongchuam","year":"2020","unstructured":"Thongchuam Y, Panyakaew P, Bhidayasiri R (2020) Orofacial dystonia and asssociated bulbar symptoms in multiple system atrophy: A blinded video analysis. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2020.116992","journal-title":"J Neurol Sci"},{"issue":"Pt 3","key":"2275_CR90","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/brain\/awq022","volume":"133","author":"L Timmermann","year":"2010","unstructured":"Timmermann L, Pauls KA, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, Revilla FJ, Santens P, Schnitzler A, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Peker S (2010) Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain 133(Pt 3):701\u2013712. https:\/\/doi.org\/10.1093\/brain\/awq022","journal-title":"Brain"},{"issue":"1","key":"2275_CR91","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13023-018-0854-y","volume":"13","author":"D Tonduti","year":"2018","unstructured":"Tonduti D, Panteghini C, Pichiecchio A, Decio A, Carecchio M, Reale C, Moroni I, Nardocci N, Campistol J, Garcia-Cazorla A, Perez Duenas B, Cerebral Calcification International Study G, Chiapparini L, Garavaglia B, Orcesi S (2018) Encephalopathies with intracranial calcification in children: clinical and genetic characterization. Orphanet J Rare Dis 13(1):135. https:\/\/doi.org\/10.1186\/s13023-018-0854-y","journal-title":"Orphanet J Rare Dis"},{"key":"2275_CR92","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322575","author":"T Tsuboi","year":"2020","unstructured":"Tsuboi T, Cauraugh JH, Wong JK, Okun MS, Ramirez-Zamora A (2020) Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2019-322575","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2275_CR93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.parkreldis.2017.04.013","volume":"40","author":"S Tunc","year":"2017","unstructured":"Tunc S, Bruggemann N, Baaske MK, Hartmann C, Grutz K, Westenberger A, Klein C, Munchau A, Baumer T (2017) Facial twitches in ADCY5-associated disease - Myokymia or myoclonus? An electromyography study. Parkinsonism Relat Disord 40:73\u201375. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.04.013","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"2275_CR94","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/mds.26937","volume":"32","author":"ME van Egmond","year":"2017","unstructured":"van Egmond ME, Lugtenberg CHA, Brouwer OF, Contarino MF, Fung VSC, Heiner-Fokkema MR, van Hilten JJ, van der Hout AH, Peall KJ, Sinke RJ, Roze E, Verschuuren-Bemelmans CC, Willemsen MA, Wolf NI, Tijssen MA, de Koning TJ (2017) A post hoc study on gene panel analysis for the diagnosis of dystonia. Mov Disord 32(4):569\u2013575. https:\/\/doi.org\/10.1002\/mds.26937","journal-title":"Mov Disord"},{"key":"2275_CR95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40734-018-0070-x","volume":"5","author":"ME van Egmond","year":"2018","unstructured":"van Egmond ME, Eggink H, Kuiper A, Sival DA, Verschuuren-Bemelmans CC, Tijssen MAJ, de Koning TJ (2018) Crossing barriers: a multidisciplinary approach to children and adults with young-onset movement disorders. J Clin Mov Disord 5:3. https:\/\/doi.org\/10.1186\/s40734-018-0070-x","journal-title":"J Clin Mov Disord"},{"issue":"8","key":"2275_CR96","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cgh.2013.03.012","volume":"11","author":"KH Weiss","year":"2013","unstructured":"Weiss KH, Thurik F, Gotthardt DN, Schafer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R, Zoller H, Schmidt HH, Reuner U, Hefter H, Trocello JM, Houwen RH, Ferenci P, Stremmel W, Consortium E (2013) Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol 11(8):1028\u20131035. https:\/\/doi.org\/10.1016\/j.cgh.2013.03.012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"2275_CR97","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/13543784.2018.1482274","volume":"27","author":"KH Weiss","year":"2018","unstructured":"Weiss KH, Czlonkowska A, Hedera P, Ferenci P (2018) WTX101 - an investigational drug for the treatment of Wilson disease. Expert Opin Investig Drugs 27(6):561\u2013567. https:\/\/doi.org\/10.1080\/13543784.2018.1482274","journal-title":"Expert Opin Investig Drugs"},{"issue":"8386","key":"2275_CR98","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/s0140-6736(84)92510-8","volume":"1","author":"LN Went","year":"1984","unstructured":"Went LN, Vegter-van der Vlis M, Bruyn GW (1984) Parental transmission in Huntington\u2019s disease. Lancet 1(8386):1100\u20131102. https:\/\/doi.org\/10.1016\/s0140-6736(84)92510-8","journal-title":"Lancet"},{"issue":"20","key":"2275_CR99","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1212\/WNL.0b013e3182563b82","volume":"78","author":"FA Wijburg","year":"2012","unstructured":"Wijburg FA, Sedel F, Pineda M, Hendriksz CJ, Fahey M, Walterfang M, Patterson MC, Wraith JE, Kolb SA (2012) Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology 78(20):1560\u20131567. https:\/\/doi.org\/10.1212\/WNL.0b013e3182563b82","journal-title":"Neurology"},{"key":"2275_CR100","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jocn.2020.03.025","volume":"75","author":"KA Woo","year":"2020","unstructured":"Woo KA, Kim HJ, Yoo D, Choi JH, Shin J, Park S, Kim R, Jeon B (2020) Patient-reported responses to medical treatment in primary dystonia. J Clin Neurosci 75:242\u2013244. https:\/\/doi.org\/10.1016\/j.jocn.2020.03.025","journal-title":"J Clin Neurosci"},{"key":"2275_CR101","doi-asserted-by":"publisher","first-page":"108284","DOI":"10.1016\/j.mrrev.2019.108284","volume":"782","author":"Y Xu","year":"2019","unstructured":"Xu Y, Zhang Q, Tan L, Xie X, Zhao Y (2019) The characteristics and biological significance of NPC2: mutation and disease. Mutat Res 782:108284. https:\/\/doi.org\/10.1016\/j.mrrev.2019.108284","journal-title":"Mutat Res"},{"issue":"3","key":"2275_CR102","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/ggi.12004","volume":"13","author":"M Yamada","year":"2013","unstructured":"Yamada M, Asano T, Okamoto K, Hayashi Y, Kanematsu M, Hoshi H, Akaiwa Y, Shimohata T, Nishizawa M, Inuzuka T, Hozumi I (2013) High frequency of calcification in basal ganglia on brain computed tomography images in Japanese older adults. Geriatr Gerontol Int 13(3):706\u2013710. https:\/\/doi.org\/10.1111\/ggi.12004","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"2275_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.genhosppsych.2013.08.007","volume":"36","author":"PC Zimbrean","year":"2014","unstructured":"Zimbrean PC, Schilsky ML (2014) Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry 36(1):53\u201362. https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.08.007","journal-title":"Gen Hosp Psychiatry"},{"issue":"9","key":"2275_CR104","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/mds.23751","volume":"26","author":"G Zorzi","year":"2011","unstructured":"Zorzi G, Zibordi F, Chiapparini L, Bertini E, Russo L, Piga A, Longo F, Garavaglia B, Aquino D, Savoiardo M, Solari A, Nardocci N (2011) Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord 26(9):1756\u20131759. https:\/\/doi.org\/10.1002\/mds.23751","journal-title":"Mov Disord"},{"issue":"3","key":"2275_CR105","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpn.2019.02.001","volume":"23","author":"V Zouvelou","year":"2019","unstructured":"Zouvelou V, Yubero D, Apostolakopoulou L, Kokkinou E, Bilanakis M, Dalivigka Z, Nikas I, Kollia E, Perez-Duenas B, Macaya A, Marce-Grau A, Voutetakis A, Anagnostopoulou K, Kekou K, Sofocleus C, Veltra D, Kokkinis X, Fryssira H, Torres RJ, Amstrong J, Santorelli FM, Artuch R, Pons R (2019) The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center. Eur J Paediatr Neurol 23(3):427\u2013437. https:\/\/doi.org\/10.1016\/j.ejpn.2019.02.001","journal-title":"Eur J Paediatr Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02275-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-020-02275-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02275-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T02:04:38Z","timestamp":1620266678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-020-02275-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2275"],"URL":"https:\/\/doi.org\/10.1007\/s00702-020-02275-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"type":"print","value":"0300-9564"},{"type":"electronic","value":"1435-1463"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}